These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 15572167

  • 1. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?
    Gysling K, Forray MI, Haeger P, Daza C, Rojas R.
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):116-25. PubMed ID: 15572167
    [Abstract] [Full Text] [Related]

  • 2. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
    Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF.
    Nat Genet; 2000 Apr; 24(4):410-4. PubMed ID: 10742108
    [Abstract] [Full Text] [Related]

  • 3. Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress.
    Pournajafi-Nazarloo H, Partoo L, Sanzenbacher L, Azizi F, Carter CS.
    Neuroendocrinology; 2007 Apr; 86(1):17-25. PubMed ID: 17551267
    [Abstract] [Full Text] [Related]

  • 4. The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family.
    Davidson SM, Rybka AE, Townsend PA.
    Biochem Pharmacol; 2009 Jan 15; 77(2):141-50. PubMed ID: 18817752
    [Abstract] [Full Text] [Related]

  • 5. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.
    Müller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, Kormann MS, Droste SK, Kühn R, Reul JM, Holsboer F, Wurst W.
    Nat Neurosci; 2003 Oct 15; 6(10):1100-7. PubMed ID: 12973355
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.
    Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC.
    Horm Metab Res; 2007 Feb 15; 39(2):166-70. PubMed ID: 17326013
    [Abstract] [Full Text] [Related]

  • 7. Neuropeptide urocortin 1 and its receptors are expressed in the human liver.
    Simopoulos C, Christodoulou E, Lambropoulou M, Tsaroucha AK, Kakolyris S, Polychronidis A, Karayiannakis AJ, Chatzaki E.
    Neuroendocrinology; 2009 Feb 15; 89(3):315-26. PubMed ID: 19096201
    [Abstract] [Full Text] [Related]

  • 8. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
    Makino S, Tanaka Y, Nazarloo HP, Noguchi T, Nishimura K, Hashimoto K.
    Brain Res; 2005 Jun 28; 1048(1-2):131-7. PubMed ID: 15919058
    [Abstract] [Full Text] [Related]

  • 9. Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells.
    Charalampopoulos I, Androulidaki A, Minas V, Chatzaki E, Tsatsanis C, Notas G, Xidakis C, Kolios G, Kouroumalis E, Margioris AN, Gravanis A.
    Neuroendocrinology; 2006 Jun 28; 84(1):49-57. PubMed ID: 17090973
    [Abstract] [Full Text] [Related]

  • 10. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
    Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC.
    J Pharmacol Exp Ther; 1999 Mar 28; 288(3):1349-56. PubMed ID: 10027877
    [Abstract] [Full Text] [Related]

  • 11. Modulation of corticotropin-releasing hormone receptor type 2 mRNA expression by CRH deficiency or stress in the mouse heart.
    Pournajafi Nazarloo H, Tanaka Y, Dorobantu M, Hashimoto K.
    Regul Pept; 2003 Sep 15; 115(2):131-8. PubMed ID: 12972328
    [Abstract] [Full Text] [Related]

  • 12. The type 2 corticotrophin-releasing hormone receptor mediates orexin A-induced luteinising hormone suppression in ovariectomised rats.
    Iwasa T, Matsuzaki T, Kiyokawa M, Shimizu F, Minakuchi M, Kuwahara A, Maegawa M, Yasui T, Irahara M.
    J Neuroendocrinol; 2007 Sep 15; 19(9):732-8. PubMed ID: 17680889
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [cDNA cloning and analysis of tissue-specific gene expression of rat urocortin II].
    Chae JI, Ju SK, Lee MK, Park JH, Yoon JH, Shim JH, Lee DS.
    Mol Biol (Mosk); 2009 Sep 15; 43(1):91-6. PubMed ID: 19334530
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression profiling identifies the CRH/CRH-R1 system as a modulator of neurovascular gene activity.
    Deussing JM, Kühne C, Pütz B, Panhuysen M, Breu J, Stenzel-Poore MP, Holsboer F, Wurst W.
    J Cereb Blood Flow Metab; 2007 Aug 15; 27(8):1476-95. PubMed ID: 17293846
    [Abstract] [Full Text] [Related]

  • 19. Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland.
    Squillacioti C, De Luca A, Liguori G, Paino S, Mirabella N.
    Gen Comp Endocrinol; 2011 Jul 01; 172(3):416-22. PubMed ID: 21504748
    [Abstract] [Full Text] [Related]

  • 20. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y, Ikeda K, Tojo K, Sakamoto M, Takada Y, Tajima N.
    Peptides; 2009 Feb 01; 30(2):365-72. PubMed ID: 19026699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.